CF and non-CF bronchiectasis

CF and non-CF bronchiectasis

Three-dimensional assessment of bronchiectasis in a mouse model of mucociliary clearance disorder
Willi Wagner, Christian Dullin, Stefan Andreas, Muriel Lizé

ERJ Open Research Jan 2021, 7 (1) 00635-2020; DOI: 10.1183/23120541.00635-2020
COVID-PCD: a participatory research study on the impact of COVID-19 in people with primary ciliary dyskinesia
Eva S.L. Pedersen, Eugénie N.R. Collaud, Rebeca Mozun, Cristina Ardura-Garcia, Yin Ting Lam, Amanda Harris, Jane S. Lucas, Fiona Copeland, Michele Manion, Bernhard Rindlisbacher, Hansruedi Silberschmidt, Myrofora Goutaki, Claudia E. Kuehni

ERJ Open Research Jan 2021, 7 (1) 00843-2020; DOI: 10.1183/23120541.00843-2020
Chronic infection by nontypeable Haemophilus influenzae fuels airway inflammation
Fabio Saliu, Giulia Rizzo, Alessandra Bragonzi, Lisa Cariani, Daniela M. Cirillo, Carla Colombo, Valeria Daccò, Daniela Girelli, Sara Rizzetto, Barbara Sipione, Cristina Cigana, Nicola I. Lorè

ERJ Open Research Jan 2021, 7 (1) 00614-2020; DOI: 10.1183/23120541.00614-2020
Chest physiotherapy enhances detection of Pseudomonas aeruginosa in nonexpectorating children with cystic fibrosis
Christophe Marguet, Véronique Houdouin, Isabelle Pin, Philippe Reix, Frédéric Huet, Marie Mittaine, Sophie Ramel, Nathalie Wizla-Derambure, Michel Abely, Marie-Laure Dalphin, Michael Fayon, Tiphaine Bihouée, Muriel Le Bourgeois, Eric Deneuville, Harriet Corvol, Muriel Laurans, Laure Couderc, Evelyne Leroux, Ludovic Lémée

ERJ Open Research Jan 2021, 7 (1) 00513-2020; DOI: 10.1183/23120541.00513-2020
What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey
Michal Shteinberg, Jeanette Boyd, Stefano Aliberti, Eva Polverino, Bridget Harris, Tove Berg, Annette Posthumus, Thomas Ruddy, Pieter Goeminne, Ernie Lloyd, Timothy Alan, Josje Altenburg, Barbara Crossley, Francesco Blasi, James Chalmers

ERJ Open Research Jan 2021, 7 (1) 00807-2020; DOI: 10.1183/23120541.00807-2020
The role of high-flow nasal therapy in bronchiectasis: a post hoc analysis
William R. Good, Jeffrey Garrett, Hans U.P. Hockey, Lata Jayaram, Conroy Wong, Harold Rea

ERJ Open Research Jan 2021, 7 (1) 00711-2020; DOI: 10.1183/23120541.00711-2020
First clinical trials of the inhaled epithelial sodium channel inhibitor BI 1265162 in healthy volunteers
Alison Mackie, Juliane Rascher, Marion Schmid, Verena Endriss, Tobias Brand, Wolfgang Seibold

ERJ Open Research Jan 2021, 7 (1) 00447-2020; DOI: 10.1183/23120541.00447-2020
Lumacaftor/ivacaftor-associated health stabilisation in adults with severe cystic fibrosis
Susannah J. King, Dominic Keating, Elyssa Williams, Eldho Paul, Brigitte M. Borg, Felicity Finlayson, Brenda M. Button, John W. Wilson, Tom Kotsimbos

ERJ Open Research Jan 2021, 7 (1) 00203-2020; DOI: 10.1183/23120541.00203-2020
Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion
Michael D. Kim, Nathalie Baumlin, John S. Dennis, Makoto Yoshida, Adrian Kis, Carolina Aguiar, Andreas Schmid, Eliana Mendes, Matthias Salathe

ERJ Open Research Jan 2021, 7 (1) 00394-2020; DOI: 10.1183/23120541.00394-2020
Avatar acceptability: views from the Australian Cystic Fibrosis community on the use of personalised organoid technology to guide treatment decisions
Laura K. Fawcett, Claire E. Wakefield, Sheila Sivam, Peter G. Middleton, Peter Wark, John Widger, Adam Jaffe, Shafagh A. Waters

ERJ Open Research Jan 2021, 7 (1) 00448-2020; DOI: 10.1183/23120541.00448-2020

Main menu

User menu

Search

CF and non-CF bronchiectasis

Pages

Contact us